Rezon Bio

Executive Summary

Rezon Bio is a next-generation Contract Development and Manufacturing Organization (CDMO) based in Warsaw, Poland, specializing in biologics for oncology and immunology. Founded in 2021, the company offers end-to-end services from process development and analytics to GMP manufacturing, with a focus on antibody-based therapeutics. Leveraging scientific expertise and strategic partnerships, Rezon Bio aims to accelerate client programs from clinic to market, positioning itself as a key player in the growing European biologics CDMO market. With a team of 200–500 employees, the company is well-funded and poised for expansion, targeting the increasing demand for outsourced biologics manufacturing. Its location in Poland provides cost advantages while maintaining high-quality standards, making it an attractive partner for biotech and pharma companies seeking efficient and reliable manufacturing solutions. Rezon Bio's comprehensive service offerings and commitment to innovation position it strongly in the competitive CDMO landscape, with potential for further growth as it scales operations and builds its client portfolio.

Upcoming Catalysts (preview)

• Q4 2026Completion of New GMP Manufacturing Facility80% success
• Q2 2026Strategic Partnership with Major Pharma for Antibody Manufacturing60% success
• Q1 2027Expansion into Cell and Gene Therapy Manufacturing50% success